CDH1 and neoplasm: Importantly, overexpression of Cripto-1 can be detected in about half of the biopsies from lung adenocarcinoma (LAC) patients where it correlates with several clinical and pathological parameters, including tumor size, lymph involvement, advanced TNM clinical stages [54], and loss of E-cadherin expression.